4.7 Article

Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease

期刊

KIDNEY INTERNATIONAL
卷 80, 期 12, 页码 1344-1351

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2011.240

关键词

health literacy; kidney disease; objective knowledge; patient knowledge; perceived knowledge

资金

  1. NIH, National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK007569, K23 DK080952-02S1, K24 DK062849]
  2. American Kidney Fund, Clinical Scientist in Nephrology Fellowship

向作者/读者索取更多资源

It is likely that patients with chronic kidney disease (CKD) have a limited understanding of their illness. Here we studied the relationships between objective and perceived knowledge in CKD using the Kidney Disease Knowledge Survey and the Perceived Kidney Disease Knowledge Survey. We quantified perceived and objective knowledge in 399 patients at all stages of non-dialysis-dependent CKD. Demographically, the patient median age was 58 years, 47% were women, 77% had stages 3-5 CKD, and 83% were Caucasians. The overall median score of the perceived knowledge survey was 2.56 (range: 1-4), and this new measure exhibited excellent reliability and construct validity. In unadjusted analysis, perceived knowledge was associated with patient characteristics defined a priori, including objective knowledge and patient satisfaction with physician communication. In adjusted analysis, older age, male gender, and limited health literacy were associated with lower perceived knowledge. Additional analysis revealed that perceived knowledge was associated with significantly higher odds (2.13), and objective knowledge with lower odds (0.91), of patient satisfaction with physician communication. Thus, our results present a mechanism to evaluate distinct forms of patient kidney knowledge and identify specific opportunities for education tailored to patients with CKD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury

Sandeep Brar, Kathleen D. Liu, Alan S. Go, Raymond K. Hsu, Vernon M. Chinchilli, Steven G. Coca, Amit X. Garg, Jonathan Himmelfarb, T. Alp Ikizler, James Kaufman, Paul L. Kimmel, Chirag R. Parikh, Edward D. Siew, Lorraine B. Ware, Hui Zeng, Chi-yuan Hsu

Summary: The study found that the use of ACEI/ARB after hospital discharge did not increase the risk of recurrent AKI in patients with or without previous AKI during hospitalization. Additionally, there were no significant differences in the risks of death, kidney disease progression, and adjudicated heart-failure events between patients who did and did not experience AKI during hospitalization.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Medicine, Research & Experimental

Biomarkers of inflammation and repair in kidney disease progression

Jeremy Puthumana, Heather Thiessen-Philbrook, Leyuan Xu, Steven G. Coca, Amit X. Garg, Jonathan Himmelfarb, Pavan K. Bhatraju, T. Alp Ikizler, Edward D. Siew, Lorraine B. Ware, Kathleen D. Liu, Alan S. Go, James S. Kaufman, Paul L. Kimmel, Vernon M. Chinchilli, Lloyd G. Cantley, Chirag R. Parikh

Summary: The study found that levels of MCP-1 and YKL-40 measured at 3 months after hospitalization were associated with long-term risk of kidney failure, while UMOD levels were linked with decreased risk of kidney injury. Using a multimarker score provided better accuracy in predicting patients' risk of kidney disease progression compared to traditional clinical variables.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Editorial Material Urology & Nephrology

Better Nutrition Care for Patients on Hemodialysis One Step at a Time

T. Alp Ikizler

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Editorial Material Urology & Nephrology

Rescuing kidney patients from early demise: role of anti-cytokine therapies

T. Alp Ikizler, Jonathan Himmelfarb

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury

Sherry G. Mansour, Pavan K. Bhatraju, Steven G. Coca, Wassim Obeid, Francis P. Wilson, Ian B. Stanaway, Yaqi Jia, Heather Thiessen-Philbrook, Alan S. Go, T. Alp Ikizler, Edward D. Siew, Vernon M. Chinchilli, Chi-yuan Hsu, Amit X. Garg, W. Brian Reeves, Kathleen D. Liu, Paul L. Kimmel, James S. Kaufman, Mark M. Wurfel, Jonathan Himmelfarb, Samir M. Parikh, Chirag R. Parikh, ASSESS-AKI Consortium

Summary: A higher Angpt-1:Angpt-2 ratio is strongly associated with reduced risk of CKD progression, heart failure, and mortality in patients with AKI.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Hematology

Hematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors

Melis Sahinoz, James M. Luther, Mona Mashayekhi, Dae Kwang Jung, T. Alp Ikizler, Brian G. Engelhardt

Summary: Cancer survivors have an increased risk of developing type 2 diabetes, and the interaction between cancer and body mass index (BMI) can affect insulin sensitivity and glucose regulation.

BLOOD ADVANCES (2022)

Editorial Material Nutrition & Dietetics

Very low-protein diets in advanced kidney disease: safe, effective, but not practical

T. Alp Ikizler

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

Editorial Material Urology & Nephrology

Aquaporin-1 variants: a step further towards precise prescription in peritoneal dialysis?

Osama El Shamy, T. Alp Ikizler

KIDNEY INTERNATIONAL (2022)

Article Urology & Nephrology

Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency

Nan Guan, Hanako Kobayashi, Ken Ishii, Olena Davidoff, Feng Sha, Talat A. Ikizler, Chuan-Ming Hao, Navdeep S. Chandel, Volker H. Haase

Summary: This study investigates the role of mitochondrial electron transport in kidney homeostasis by inactivating a subunit of mitochondrial complex III in kidney progenitor cells. The results show that mitochondrial oxidative metabolism is critical for kidney development, and inactivation of specific proteins can lead to severe kidney dysplasia or smaller functional kidneys.

KIDNEY INTERNATIONAL (2022)

Editorial Material Urology & Nephrology

Dietary sodium restriction in heart failure and chronic kidney disease: more evidence emerges

Rengin Elsurer Afsar, Talat Alp Ikizler

KIDNEY INTERNATIONAL (2022)

Article Urology & Nephrology

The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events

Steven Menez, Yumeng Wen, Leyuan Xu, Dennis G. Moledina, Heather Thiessen-Philbrook, David Hu, Wassim Obeid, Pavan K. Bhatraju, T. Alp Ikizler, Edward D. Siew, Vernon M. Chinchilli, Amit X. Garg, Alan S. Go, Kathleen D. Liu, James S. Kaufman, Paul L. Kimmel, Jonathan Himmelfarb, Steven G. Coca, Lloyd G. Cantley, Chirag R. Parikh

Summary: Urinary epidermal growth factor (EGF) may serve as a biomarker for tubular function and can be used to assess the risk of chronic kidney disease (CKD) after hospitalization. Higher urinary EGF concentrations three months post-discharge are associated with a reduced risk of major adverse kidney events (MAKE), such as CKD incidence, progression, or kidney failure.

KIDNEY INTERNATIONAL (2023)

Article Urology & Nephrology

Effects of Spironolactone on Arrhythmias in Hemodialysis Patients: Secondary Results of the SPin-D Randomized Controlled Trial

Finnian R. Mc Causland, Jesse Y. Hsu, Jonathan Himmelfarb, Talat Alp Ikizler, Dominic S. Raj, Rajnish Mehrotra, Sushrut S. Waikar, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember, David M. Charytan

Summary: In a post hoc analysis, it was found that spironolactone treatment resulted in a higher frequency of bradycardia and conduction blocks in patients receiving maintenance hemodialysis. Close monitoring is necessary for these patients while awaiting definitive trial results.

KIDNEY360 (2023)

Review Urology & Nephrology

Skeletal muscle energetics in patients with moderate to advanced kidney disease

Lale Ertuglu, Abdulmecit Yildiz, Jorge Gamboa, T. Alp Ikizler

Summary: Sarcopenia, characterized by decreased muscle function and mass, is common in patients with moderate to advanced chronic kidney disease (CKD) and is associated with poor clinical outcomes. Mitochondrial dysfunction is proposed as one of the underlying mechanisms, which is noticeable from the early stages and correlated with disease severity. Uremic toxins, oxidative stress, and systemic inflammation play a role in the development of mitochondrial dysfunction. Therapeutic interventions targeting mitochondrial function, such as coenzyme Q and cardiolipin-targeted peptides, have been tested in early studies. Aerobic exercise, although effective in healthy adults, is not as effective in advanced CKD patients, potentially due to impaired activation of mitochondrial biogenesis. Further research is needed to better understand the pathogenesis of mitochondrial dysfunction and develop targeted therapies for sarcopenia in CKD patients.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2022)

Article Urology & Nephrology

Peripheral Insulin Resistance Is Associated with Copeptin in Patients with Chronic Kidney Disease

Juan Pablo Arroyo, Elvis A. Akwo, Andrew S. Terker, Aseel Alsouqi, Gautam Bhave, Raymond C. Harris, Adriana M. Hung, T. Alp Ikizler

Summary: The study found a significant correlation between peripheral insulin resistance and elevated copeptin levels in patients with CKD, with a 39% increase in copeptin levels for every 1 SD decrease in insulin sensitivity. Further research into how peripheral insulin resistance and elevated vasopressin affect CKD progression could provide valuable insights.

KIDNEY360 (2021)

Article Urology & Nephrology

The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study

Dominic S. Raj, Michael B. Sohn, David M. Charytan, Jonathan Himmelfarb, T. Alp Ikizler, Rajnish Mehrotra, Ali Ramezani, Renu Regunathan-Shenk, Jesse Y. Hsu, J. Richard Landis, Hongzhe Li, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember

Summary: The study found that there is greater variability in gut microbiome and metabolomic composition between individuals with ESKD than within individuals. Treatment with p-inulin was well tolerated and showed signs of increasing microbiome diversity.

KIDNEY360 (2021)

暂无数据